(Q38135358)

29 August 2017

title

Managing tobacco use: the neglected cardiovascular disease risk factor (English)

1 reference

29 August 2017

0 references

cardiovascular disease

1 reference

2

Carole Clair

1 reference

29 August 2017

1

Nancy A Rigotti

1 reference

29 August 2017

publication date

7 September 2013

1 reference

29 August 2017

published in

European Heart Journal

1 reference

29 August 2017

volume

34

1 reference

29 August 2017

issue

42

1 reference

29 August 2017

page(s)

3259-3267

1 reference

21st-century hazards of smoking and benefits of cessation in the United States

29 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHT352

European Guidelines on cardiovascular disease prevention in clinical practice (version 2012). The Fifth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHT352

Cardiovascular prevention guidelines in daily practice: a comparison of EUROASPIRE I, II, and III surveys in eight European countries

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHT352

AHA/ACCF Secondary Prevention and Risk Reduction Therapy for Patients with Coronary and other Atherosclerotic Vascular Disease: 2011 update: a guideline from the American Heart Association and American College of Cardiology Foundation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHT352

Use of smokeless tobacco and risk of myocardial infarction and stroke: systematic review with meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHT352

50-year trends in smoking-related mortality in the United States

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHT352

Prevalence, risk factors and cardiovascular comorbidity of symptomatic peripheral arterial disease in Italy

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHT352

Factors associated with development of large abdominal aortic aneurysm in middle-aged men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHT352

Nicotine, cigarette smoking and cardiac arrhythmia: an overview

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHT352

Smoking and cardiac events after venous coronary bypass surgery. A 15-year follow-up study

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHT352

Frequency and predictors of stent thrombosis after percutaneous coronary intervention in acute myocardial infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHT352

Narrative review: aspirin resistance and its clinical implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHT352

The association of cigarette smoking with enhanced platelet inhibition by clopidogrel

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHT352

Smoking, clopidogrel, and mortality in patients with established cardiovascular disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHT352

Passive smoking and the risk of coronary heart disease--a meta-analysis of epidemiologic studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHT352

Worldwide burden of disease from exposure to second-hand smoke: a retrospective analysis of data from 192 countries

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHT352

Cardiovascular effect of bans on smoking in public places: a systematic review and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHT352

Smoking and endothelial function

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHT352

Cigarette smoking and cardiovascular disease: pathophysiology and implications for treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHT352

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHT352

Oxidative stress and smoking-induced vascular injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHT352

Active Smoking and the Risk of Type 2 Diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHT352

Smoking, lipoproteins and coronary heart disease risk. Data from the Münster Heart Study (PROCAM).

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHT352

Chronic cigarette smoking causes hypertension, increased oxidative stress, impaired NO bioavailability, endothelial dysfunction, and cardiac remodeling in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHT352

Meta-analysis of relation between cigarette smoking and stroke

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHT352

Association of diet, exercise, and smoking modification with risk of early cardiovascular events after acute coronary syndromes

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHT352

Mortality risk reduction associated with smoking cessation in patients with coronary heart disease: a systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHT352

Smoking Status on Outcomes After Percutaneous Coronary Intervention

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHT352

Recommendation for the assessment of tobacco craving and withdrawal in smoking cessation trials.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHT352

Varenicline, an alpha4beta2 nicotinic acetylcholine receptor partial agonist, vs sustained-release bupropion and placebo for smoking cessation: a randomized controlled trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHT352

The case for treating tobacco dependence as a chronic disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHT352

Strategies to help a smoker who is struggling to quit

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHT352

Placebo-controlled trial of cytisine for smoking cessation

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHT352

Comparative effectiveness of 5 smoking cessation pharmacotherapies in primary care clinics

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHT352

The Safety of Transdermal Nicotine as an Aid to Smoking Cessation in Patients with Cardiac Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHT352

Cardiovascular safety of transdermal nicotine patches in patients with coronary artery disease who try to quit smoking

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHT352

Safety issues in pharmacotherapy for smoking in patients with cardiovascular disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHT352

Efficacy of varenicline, an alpha4beta2 nicotinic acetylcholine receptor partial agonist, vs placebo or sustained-release bupropion for smoking cessation: a randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHT352

Varenicline versus transdermal nicotine patch for smoking cessation: results from a randomised open-label trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHT352

Efficacy and safety of varenicline for smoking cessation in patients with cardiovascular disease: a randomized trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHT352

Risk of serious adverse cardiovascular events associated with varenicline: a systematic review and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHT352

Risk of cardiovascular serious adverse events associated with varenicline use for tobacco cessation: systematic review and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHT352

Psychiatric adverse events in randomized, double-blind, placebo-controlled clinical trials of varenicline: a pooled analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHT352

Varenicline and suicidal behaviour: a cohort study based on data from the General Practice Research Database.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHT352

Neuropsychiatric events in varenicline and nicotine replacement patch users in the Military Health System

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHT352

Bupropion SR for smoking cessation in smokers with cardiovascular disease: a multicentre, randomised study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHT352

Bupropion for smokers hospitalized with acute cardiovascular disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHT352

Projected cost-effectiveness of smoking cessation interventions in patients hospitalized with myocardial infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHT352

Cardiology Rx for Change: improving clinical attention to tobacco use and secondhand smoke exposure in cardiology.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHT352

Tobacco use and risk of myocardial infarction in 52 countries in the INTERHEART study: a case-control study

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHT352

Bupropion for Smoking Cessation in Patients Hospitalized With Acute Myocardial Infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHT352

Reduction versus abrupt cessation in smokers who want to quit

21 January 2018

1 reference

COCI

https://opencitations.net/index/api/v1/citations/10.1002/14651858.CD008033.PUB3

9 February 2024

Identifiers

DOI

10.1093/EURHEARTJ/EHT352

1 reference

29 August 2017

1 reference